TY - JOUR
T1 - Cholinergic systems
T2 - Human diseases, animal models, and prospects for therapy
AU - Price, Donald L.
AU - Koliatsos, Vassilis E.
AU - Clatterbuck, Richard C.
N1 - Funding Information:
The authors thank Drs. Linda C. Cork, Lary C. Walker, Allan I. Levey, Cheryl A. Kitt, Carlos A. Pardo and Sangram S. Sisodia for helpful discussions. These studies were supported by grants from the U.S. Public Health Service (NIH AG 05146, NS 20471, NS 07179) as well as the American Health Assistance Foundation and the Metropolitan Life Foundation. Dr. Price is the recipient of a Leadership and Excellence in Alzheimer's Disease (LEAD) award (AG 07914) and a Javits Neuroscience Investigator Award (NS 10580).
PY - 1993/1/1
Y1 - 1993/1/1
N2 - Cholinergic neurons, including those in the basal forebrain, brainstem, and spinal cord, play critical roles in the functions of a variety of neural circuits, and abnormalities of these neuronal populations are responsible for the clinical manifestations of several human neurological disorders. In Alzheimer's disease (AD), basal forebrain cholinergic neurons are among the vulnerable populations of neurons. In individuals with amyotrophic lateral sclerosis (ALS), large motor neurons of the brainstem and spinal cord degenerate, whereas patients with multiple system atrophy (Shy-Drager syndrome) show lesions of cholinergic cells in Onufrowicz's (Onuf's) nucleus and the intermediolateral cell column of the spinal cord. In each of these illnesses, the dysfunction and death of these neurons are linked to the clinical phenotypes of disease— that is, impairments in attention, learning, and memory in AD, weakness in ALS, and impotence, incontinence and orthostatic hypertension in Shy-Drager syndrome. Recent studies suggest that different populations of cholinergic neurons may respond to different trophic factors, raising the possibility that, in the future, trophic factors may be used to preserve the functions and promote the survival of these subsets of nerve cells. This chapter outlines the current understanding of the involvement of these cholinergic systems in several human diseases and their respective animal models, and suggests directions of research that may lead to future trophic factor therapeutic approaches to restore the functions of these systems.
AB - Cholinergic neurons, including those in the basal forebrain, brainstem, and spinal cord, play critical roles in the functions of a variety of neural circuits, and abnormalities of these neuronal populations are responsible for the clinical manifestations of several human neurological disorders. In Alzheimer's disease (AD), basal forebrain cholinergic neurons are among the vulnerable populations of neurons. In individuals with amyotrophic lateral sclerosis (ALS), large motor neurons of the brainstem and spinal cord degenerate, whereas patients with multiple system atrophy (Shy-Drager syndrome) show lesions of cholinergic cells in Onufrowicz's (Onuf's) nucleus and the intermediolateral cell column of the spinal cord. In each of these illnesses, the dysfunction and death of these neurons are linked to the clinical phenotypes of disease— that is, impairments in attention, learning, and memory in AD, weakness in ALS, and impotence, incontinence and orthostatic hypertension in Shy-Drager syndrome. Recent studies suggest that different populations of cholinergic neurons may respond to different trophic factors, raising the possibility that, in the future, trophic factors may be used to preserve the functions and promote the survival of these subsets of nerve cells. This chapter outlines the current understanding of the involvement of these cholinergic systems in several human diseases and their respective animal models, and suggests directions of research that may lead to future trophic factor therapeutic approaches to restore the functions of these systems.
UR - http://www.scopus.com/inward/record.url?scp=0027437722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027437722&partnerID=8YFLogxK
U2 - 10.1016/S0079-6123(08)62380-8
DO - 10.1016/S0079-6123(08)62380-8
M3 - Article
C2 - 8248537
AN - SCOPUS:0027437722
VL - 98
SP - 51
EP - 60
JO - Progress in Brain Research
JF - Progress in Brain Research
SN - 0079-6123
IS - C
ER -